186 related articles for article (PubMed ID: 9088829)
1. Review of clinical experience of desmopressin in patients with congenital and acquired bleeding disorders.
Cattaneo M
Eur J Anaesthesiol Suppl; 1997 Mar; 14():10-4; discussion 14-8. PubMed ID: 9088829
[TBL] [Abstract][Full Text] [Related]
2. Desmopressin--a haemostatic drug: state-of-the-art review.
Lethagen S
Eur J Anaesthesiol Suppl; 1997 Mar; 14():1-9. PubMed ID: 9088828
[TBL] [Abstract][Full Text] [Related]
3. The UK guidelines for the use of desmopressin in patients with von Willebrand's disease. Von Willebrand Working Party of the United Kingdom Haemophilia Centre Director's Organization.
Lethagen S; Flordal P; Van Aken H; Hunt BJ; Cattaneo M
Eur J Anaesthesiol Suppl; 1997 Mar; 14():19-22. PubMed ID: 9088830
[TBL] [Abstract][Full Text] [Related]
4. Severe hyponatraemia secondary to desmopressin therapy in von Willebrand's disease.
Bertholini DM; Butler CS
Anaesth Intensive Care; 2000 Apr; 28(2):199-201. PubMed ID: 10788975
[TBL] [Abstract][Full Text] [Related]
5. New approaches to management of bleeding disorders.
Aledort LM
Hosp Pract (Off Ed); 1989 Feb; 24(2):207-11, 214, 219-21 passim. PubMed ID: 2493009
[No Abstract] [Full Text] [Related]
6. The use of desmopressin as a hemostatic agent: a concise review.
Franchini M
Am J Hematol; 2007 Aug; 82(8):731-5. PubMed ID: 17492648
[TBL] [Abstract][Full Text] [Related]
7. Desmopressin--a nontransfusional form of prevention of postextractive bleeding in some patients with von Willebrand's type I disease. Case report.
Rahnama M; Tomaszewski T; Swiatkowski W
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):150-3. PubMed ID: 12898917
[TBL] [Abstract][Full Text] [Related]
8. Desmopressin as a hemostatic and blood sparing agent in bleeding disorders.
Mohinani A; Patel S; Tan V; Kartika T; Olson S; DeLoughery TG; Shatzel J
Eur J Haematol; 2023 May; 110(5):470-479. PubMed ID: 36656570
[TBL] [Abstract][Full Text] [Related]
9. Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders.
Leissinger C; Carcao M; Gill JC; Journeycake J; Singleton T; Valentino L
Haemophilia; 2014 Mar; 20(2):158-67. PubMed ID: 23937614
[TBL] [Abstract][Full Text] [Related]
10. Transient focal cerebral ischaemia and bilateral pulmonary embolism after desmopressin treatment for von Willebrand's disease.
de Wee EM; Ikram MK; Dippel DW; Leebeek FW
Haemophilia; 2008 Sep; 14(5):1133-4. PubMed ID: 18665851
[No Abstract] [Full Text] [Related]
11. Desmopressin: a nontransfusional treatment of hemophilia and von Willebrand disease.
Mannucci PM; Cattaneo M
Haemostasis; 1992; 22(5):276-80. PubMed ID: 1478539
[TBL] [Abstract][Full Text] [Related]
12. Vasopressin analogues. Their role in disorders of hemostasis.
Mannuccio PM; Altieri D; Faioni E
Ann N Y Acad Sci; 1987; 509():71-81. PubMed ID: 3122621
[TBL] [Abstract][Full Text] [Related]
13. [Desmopressin in the treatment of bleeding disorders].
Tomasiak MM; Tomasiak M; Bodzenta-Lukaszyk A
Pol Arch Med Wewn; 2005 May; 113(5):509-15. PubMed ID: 16479837
[No Abstract] [Full Text] [Related]
14. PFA-100 testing for pretherapeutic assessment of response to DDAVP in patients with von Willebrand's disease.
Weston H; Just S; Williams B; Rowell J; Kennedy GA
Haemophilia; 2009 Jan; 15(1):372-3. PubMed ID: 19149861
[No Abstract] [Full Text] [Related]
15. Clinical effectiveness of desmopressin in a case of acquired von Willebrand's syndrome associated with benign monoclonal gammopathy.
Castaman G; Rodeghiero F; Di Bona E; Ruggeri M
Blut; 1989 Apr; 58(4):211-3. PubMed ID: 2784985
[TBL] [Abstract][Full Text] [Related]
16. Desmopressin: an historical introduction.
Mannucci PM
Haemophilia; 2008 Jan; 14 Suppl 1():1-4. PubMed ID: 18173688
[TBL] [Abstract][Full Text] [Related]
17. Assessment and validation of a defined fluid restriction protocol in the use of subcutaneous desmopressin for children with inherited bleeding disorders.
Mason JA; Robertson JD; McCosker J; Williams BA; Brown SA
Haemophilia; 2016 Sep; 22(5):700-5. PubMed ID: 27385253
[TBL] [Abstract][Full Text] [Related]
18. Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin.
de la Fuente B; Kasper CK; Rickles FR; Hoyer LW
Ann Intern Med; 1985 Jul; 103(1):6-14. PubMed ID: 3923887
[TBL] [Abstract][Full Text] [Related]
19. Self-treatment with desmopressin intranasal spray in patients with bleeding disorders: effect on bleeding symptoms and socioeconomic factors.
Lethagen S; Ragnarson Tennvall G
Ann Hematol; 1993 May; 66(5):257-60. PubMed ID: 8507721
[TBL] [Abstract][Full Text] [Related]
20. Common bleeding disorders: a potential catastrophe for the trauma victim. Therapeutic recommendations for the treatment of von Willebrand's disease.
Slam K; Zyromski N; Nowicki P; Serrano P; Purtill MA
J Trauma; 2008 May; 64(5):1373-5. PubMed ID: 18469664
[No Abstract] [Full Text] [Related]
[Next] [New Search]
